TREM2 and glioblastoma: The exploration of TREM2 as a therapeutic target in GBM is nascent, yet it is poised to advance rapidly with an expanding comprehension of its fundamental mechanisms that govern the survival, differentiation, and function of microglial and macrophage cells.